Patents by Inventor Christian Zurth

Christian Zurth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8671945
    Abstract: The present invention relates to the field of pharmaceutical formulation techniques. The invention provides a low dosage pharmaceutical composition for transdermal delivery of hormones, preferably a progestin, such as a Gestodene, and an estrogen, preferably Ethinylestradiol so as to achieve plasma concentration profiles effective in inhibiting ovulation in a woman.
    Type: Grant
    Filed: September 6, 2011
    Date of Patent: March 18, 2014
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Ildiko Terebesi, Christian Zurth, Hannes-Friedrich Ulbrich
  • Publication number: 20120073578
    Abstract: The present invention relates to the field of pharmaceutical formulation techniques. The invention provides a low dosage pharmaceutical composition for transdermal delivery of hormones, preferably a progestin, such as a Gestodene, and an estrogen, preferably Ethinylestradiol so as to achieve plasma concentration profiles effective in inhibiting ovulation in a woman.
    Type: Application
    Filed: September 6, 2011
    Publication date: March 29, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Ildiko TEREBESI, Christian ZURTH, Hannes-Friedrich ULBRICH
  • Patent number: 8022053
    Abstract: The present invention relates to oral solid dosage forms containing a very low dose of estradiol. The dosage forms are formulated in a manner so as to avoid degradation of the estradiol and to minimise the content of polyvinylpyrrolidone, while still achieving similar fast dissolution of the estradiol. The dosage forms are useful in preventing or treating a physical condition in a woman caused by insufficient endogenous levels of estradiol.
    Type: Grant
    Filed: November 1, 2005
    Date of Patent: September 20, 2011
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Kristina Mueller, Torsten Wagner, Adrian Funke, Christian Zurth
  • Publication number: 20110097405
    Abstract: The present invention relates to drug delivery systems in the form of thin water-soluble films (wafers), which contain estradiol, or derivatives thereof, in low amounts. The wafers of the present invention are suitable for treating, alleviating or preventing a physical condition in a female mammal caused by insufficient endogenous levels of estrogen.
    Type: Application
    Filed: February 5, 2009
    Publication date: April 28, 2011
    Applicant: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Adrian Funke, Sascha General, Ildikó Terebesi, Christian Zurth, Sofia Alincic-kunz, Matthias Schäfer, Thomas Holler, Konstanze Diefenbach
  • Publication number: 20060111334
    Abstract: The present invention relates to oral solid dosage forms containing a very low dose of estradiol. The dosage forms are formulated in a manner so as to avoid degradation of the estradiol and to minimise the content of polyvinylpyrrolidone, while still achieving similar fast dissolution of the estradiol. The dosage forms are useful in preventing or treating a physical condition in a woman caused by insufficient endogenous levels of estradiol.
    Type: Application
    Filed: November 1, 2005
    Publication date: May 25, 2006
    Inventors: Kristina Mueller, Torsten Wagner, Adrian Funke, Christian Zurth
  • Publication number: 20020136693
    Abstract: Agents containing magnetic particles are suitable for use in enhancing images in diagnostic procedures, e.g., via x-ray, ultrasound or especially NMR. Preferred particles are based on metals, e.g., iron, cobalt or nickel, double metal oxides/hydroxides or complexes thereof.
    Type: Application
    Filed: March 27, 2002
    Publication date: September 26, 2002
    Inventors: Heinz Gries, Wolfgang Mutzel, Christian Zurth, Hanns-Joachim Weinmann
  • Publication number: 20020064502
    Abstract: Agents containing magnetic particles are suitable for use in enhancing images in diagnostic procedures, e.g., via x-ray, ultrasound or especially NMR. Preferred particles are based on metals, e.g., iron, cobalt or nickel, double metal oxides/hydroxides or complexes thereof.
    Type: Application
    Filed: December 24, 1997
    Publication date: May 30, 2002
    Inventors: HEINZ GRIES, WOLFGANG MUTZEL, CHRISTIAN ZURTH, HANNS-JOACHIM WEINMANN
  • Patent number: 5746999
    Abstract: Agents containing magnetic particles are suitable for use in enhancing images in diagnostic procedures, e.g., via x-ray, ultrasound or especially NMR. Preferred particles are based on metals, e.g., iron, cobalt or nickel, double metal oxides/hydroxides or complexes thereof.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 5, 1998
    Assignee: Schering Aktiengesellschaft
    Inventors: Heinz Gries, Wolfgang Mutzel, Christian Zurth, Hanns-Joachim Weinmann